| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A US plan for HCV elimination
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
1 |
p. 1
|
article
|
| 2 |
Challenges in gastroenterology training in Australia
|
Prince, David S
|
|
|
8 |
1 |
p. 8-10
|
article
|
| 3 |
Cirrhosis and hepatocellular carcinoma at primary hospitals in sub-Saharan Africa: the opportunity of PEN-Plus
|
Gupta, Neil
|
|
|
8 |
1 |
p. 13-14
|
article
|
| 4 |
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference
|
Pollok, Joerg M
|
|
|
8 |
1 |
p. 81-94
|
article
|
| 5 |
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial
|
Sandborn, William J
|
|
|
8 |
1 |
p. 43-55
|
article
|
| 6 |
Flux Gourmet: a visual feast with a starved social mission
|
Moody, Joe
|
|
|
8 |
1 |
p. 18
|
article
|
| 7 |
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
|
Quek, Jingxuan
|
|
|
8 |
1 |
p. 20-30
|
article
|
| 8 |
Has the COVID-19 pandemic changed endoscopy in the UK forever?
|
Rees, Colin
|
|
|
8 |
1 |
p. 6-8
|
article
|
| 9 |
How to live when you could be dead
|
Bisbas, Georgia
|
|
|
8 |
1 |
p. 19
|
article
|
| 10 |
NAFLD prevalence and severity in overweight and obese populations
|
Francque, Sven M A
|
|
|
8 |
1 |
p. 2-3
|
article
|
| 11 |
New restrictions on JAK inhibitors in the EU
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
1 |
p. 1
|
article
|
| 12 |
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
|
Atia, Ohad
|
|
|
8 |
1 |
p. 31-42
|
article
|
| 13 |
Practicalities accessing precision medicine in biliary tract cancer
|
Edeline, Julien
|
|
|
8 |
1 |
p. 5-6
|
article
|
| 14 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
1 |
p. 16
|
article
|
| 15 |
Robotic versus laparoscopic surgery for middle and low rectal cancer
|
Meyer, Jeremy
|
|
|
8 |
1 |
p. 11
|
article
|
| 16 |
Robotic versus laparoscopic surgery for middle and low rectal cancer
|
Kammar, Praveen S
|
|
|
8 |
1 |
p. 11-12
|
article
|
| 17 |
Robotic versus laparoscopic surgery for middle and low rectal cancer – Authors' reply
|
Xu, Jianmin
|
|
|
8 |
1 |
p. 12-13
|
article
|
| 18 |
Séverine Vermeire: advancing patient-centred research in IBD
|
Thorley, Jennifer
|
|
|
8 |
1 |
p. 17
|
article
|
| 19 |
The intestinal barrier in disorders of the central nervous system
|
Pellegrini, Carolina
|
|
|
8 |
1 |
p. 66-80
|
article
|
| 20 |
The Liver Meeting 2022
|
Thomas, Hugh
|
|
|
8 |
1 |
p. 15
|
article
|
| 21 |
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
|
Lee, Choong-kun
|
|
|
8 |
1 |
p. 56-65
|
article
|
| 22 |
Vedolizumab in paediatric IBD: a huge step forward but not there yet
|
Klomberg, Renz C W
|
|
|
8 |
1 |
p. 3-5
|
article
|
Journal description